FIGURE 7-2 New trials received by in 2006. The average total number of new trial registrations received per month was 923; the average number of open drug trials received per month was 478; the average number of open industry drug trials received per month was 215; and the average number of open industry IND trials received per month was 162.

NOTE: IND = Investigational New Drug.

SOURCE: Zarin, 2007.

When questioned about the history and mandate of the ClinicalTrials. gov registry, Dr. Zarin responded that the registry has been functioning since 2000, although some sponsors (NIH and some drug companies) have registered older studies. The current mandates for registration include the Food and Drug Modernization Act, Section 113, which mandates registering all Investigational New Drug (IND) studies with efficacy end points for serious and life-threatening conditions, and the above-mentioned requirement of the International Committee of Medical Journal Editors to register trials for any intervention that is clinically directed as a condition for publication. Again, one of the challenges is determining whether a trial that is mandated to be registered is actually registered. In response to another question, Dr. Zarin noted that while accepts and welcomes data on nonclinical trials (i.e., observational data), it cannot enforce their inclusion.

The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement